Búsqueda avanzada

El Dr. Kuno Sommer es Presidente de Targimmune Therapeutics AG, Presidente del Consejo de Supervisión de Sunstar-Holding AG, Presidente de Polyphor AG, Presidente de Bachem Holding AG, Presidente de PDS Pathology Data Systems Co. Ag, Presidente de Kenta Biotech AG y Presidente de Bachem Americas, Inc. Forma parte del Consejo de Administración de Ferienclub Privilge AG. Anteriormente, el Dr. Sommer fue Director General de Harlan Laboratories Ltd., Director General de Berna Biotech AG, Director General de Givaudan SA, Director de F. Hoffmann-La Roche Ltd., Director de Negocios de Crucell NV, Jefe de Investigación de Contratos de Harlan Laboratories Ltd., Presidente de Pevion Biotech AG y Miembro del Comité Ejecutivo de Roche Holding AG. Obtuvo un MBA en la Universidad de Basilea y un doctorado en la Universidad de Basilea.

Kuno Schmid is currently the Head-Manager Selection at Falcon Private Bank AG.
He previously worked as a Principal at Falcon Portfolio Management Ltd.

Sachiko Kuno is the founder of VLP Therapeutics LLC (founded in 2012), R-Tech Ueno, Ltd.
(founded in 1989), S&R Technology Holdings LLC (founded in 1999), Sucampo Pharmaceuticals LLC (founded in 1996), Sucampo GmbH (founded in 1997), and S&R Foundation (founded in 2000).
Dr. Kuno's current job(s) include being an Independent Outside Director at Monex Group, Inc. since 2023, a Director at The Henry L.
Stimson Center, and a Trustee at Johns Hopkins Medicine, Inc.Dr. Kuno's former job(s) include being a Director at The Maureen & Mike Mansfield Foundation.
Dr. Kuno's education history includes undergraduate and doctorate degrees from Kyoto University.

Stephen Kuno currently works as a Director for the New York Association of Convenience Stores.